Back to search

Georgia Institute of Technology

Understanding HTLV-I Enzymology and Preparation and Characterization of Lead Inhibitors for the Treatment of HTLV-I Infection

Abstract

dc:description.abstract

The primary goals of our research are to understand the virology and enzymology of human T-cell leukemia virus type I (HTLV-I) that will lead to the development of treatments for patients infected with HTLV-I. HTLV-I is an oncogenic virus of the Retroviridae family and is the causative agent of adult T-cell leukemia/lymphoma (ATL), tropical spastic paraparesis/HTLV-I associated myelopathy (TSP/HAM). HTLV-I has been classified as a dangerous emerging pathogen by the Centers for Disease Control and Prevention with at least 20 million people infected with the virus. This is a significant problem because there are currently no effective treatments to control HTLV-I infection and prevent or treat HTLV-I induced ATL and TSP/HAM. The protease is necessary for retroviral maturation and replication and is, therefore, an attractive target for inhibitor design. Investigation of peptide mimetic compounds incorporating the tetrahedral intermediate of aspartyl protease catalyzed cleavage are crucial for the development of lead inhibitors. Compounds containing statine, 4-amino-3-hydroxy-5-phenylpentanoic acid (AHPPA), or hydroxyethylamine (HEA) are presented in this work. The best compound was a statine-based inhibitor, which had a Ki = 29 +/- 4 nM and 88% inhibition against an HTLV-I protease native substrate in a FRET assay.

Degree

thesis:*
Department dc:contributor.department
Chemistry and Biochemistry
Grantor dc:publisher
Georgia Institute of Technology
Year dc:date.issued
2005

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Dennison, Kelly Joy
Advisors dc:contributor.advisor
  • Shuker, Suzanne B.
  • Orlando, Thomas M.
Committee members dc:contributor.committeemember
  • Andreas S. Bommarius
  • Sherrill, C. David
  • Doyle, Donald F.
  • S. Michele Owen

Subjects

dc:subject × 6

Rights

Language dc:language.iso
en_US

Identifiers

dc:identifier.*
Handle dc:identifier.uri
http://hdl.handle.net/1853/7582

Chain of custody

source
Harvested from
Georgia Tech
Base URL
repository.gatech.edu/server/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Dennison, Kelly Joy. Understanding HTLV-I Enzymology and Preparation and Characterization of Lead Inhibitors for the Treatment of HTLV-I Infection. Georgia Institute of Technology, 2005. http://hdl.handle.net/1853/7582